Evidence map›Paper›PMID 40977539›Full record

ArticleThe Journal of infectious diseases2025

The Major Outer Membrane Protein P5 Binds Vitronectin to Mediate Serum Resistance in Nontypeable Haemophilus influenzae.

Sandra Jonsson, Martina Janoušková, Vaishnavi Venkatesh Rao, Junkal Garmendia, Yu-Ching Su, Kristian Riesbeck

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sandra JonssonClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0000-0002-0666-3951
Martina JanouškováClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0000-0002-3681-9179
Vaishnavi Venkatesh RaoClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Junkal GarmendiaInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Spain.ORCID 0000-0002-7440-2737
Yu-Ching SuClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0000-0003-3398-6294
Kristian RiesbeckClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0000-0001-6274-6965

Funding

Anna and Edwin Berger FoundationKnut and Alice Wallenberg Foundation 2018.0318Lars Hierta Memorial FoundationRoyal Physiographical Society of LundSkåne County Council's Research and Development FoundationSwedish Heart Lung Foundation 20210277Swedish Heart Lung Foundation 20240666Swedish Research Council 2023-02022
6 · The paper itself

Abstract

Acquisition of complement regulators is a virulence strategy used by nontypeable Haemophilus influenzae (NTHi) to evade complement-mediated killing by the host. The major outer membrane protein of NTHi, P5, binds C4b-binding protein and factor H to promote bacterial serum resistance. We show that P5 also binds vitronectin, which inhibits the formation of the membrane attack complex at the terminal stage of the complement pathway. Heterologous surface expression of P5 variants from NTHi strains 3655, KR271, KR317, and P652 promoted vitronectin binding to the P5-expressing Escherichia coli. In contrast, deletion of P5 from the NTHi strains reduced vitronectin binding. Vitronectin acquisition conferred serum resistance to P5-expressing E. coli, but not to NTHi ΔompP5 mutants. Using site-directed mutagenesis, extracellular loop 2 of the P5 variants was identified as the binding site for vitronectin. In conclusion, our findings highlight P5 as a receptor for vitronectin that promotes NTHi serum resistance.

Indexed as

Bacterial Outer Membrane ProteinsHaemophilus influenzaeVitronectinBlood Bactericidal ActivityEscherichia coliHaemophilus InfectionsHumansProtein BindingBacterial Outer Membrane ProteinsVitronectincomplement inhibitornontypeable Haemophilus influenzaeOMP P5serum resistancevitronectin

Identifiers

PMID40977539
PMCPMC12718013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.